A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

Hit your running and weight loss goals while on GLP-1s with the help of mindful strategies.

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

A lot happens in Boston every day. To help you keep up, WBUR, Boston's NPR News station, pulled these stories together just ...

The cost of weight loss drug Wegovy will soon be massively subsidised for Australians with severe obesity who have had a ...

Noom Med is a medically-guided weight loss program that combines clinical care with Noom's behavior-change tools. The program provides virtual consultations, medication management, and nutrition ...